Fycompa
China approves Eisai’s Fycompa for partial onset epileptic seizures
October 16, 2019Research and Development, Sales and Marketing China, Eisai, Fycompa, epilepsy, pharma
Tokyo-headquartered firm Eisai has announced that its antiepileptic drug (AED) Fycompa (perampanel) has received approval from China’s National Medical Products …
Eisai earns FDA nod for Fycompa
June 22, 2015Sales and Marketing Eisai, FDA, Fycompa
The FDA has expanded the patient groups for whom Eisai’s epilepsy drug Fycompa is available to include people who have …
Eisai epilepsy drug sees EMA nod
May 27, 2015Research and Development, Sales and Marketing Eisai, Fycompa, ema. epilepsy
Eisai’s UK subsidiary has received a positive opinion from the European Medicines Agency for using Fycompa for the adjunctive treatment …
Eisai: Fycompa decision ‘deeply regrettable’
November 11, 2014Research and Development, Sales and Marketing Eisai, Fycompa, Germany, epilepsy, gba, perampanel
Eisai has lashed out at a major German health assessment body, calling its stance on first-in-class epilepsy treatment Fycompa ‘deeply …
SMC first to give Fycompa thumbs-up
December 12, 2012Sales and Marketing Eisai, Fycompa, SMC, Scotland, epilepsy
The Scottish Medicines Consortium (SMC) has approved Eisai’s first-in-class epilepsy drug Fycompa for use in the NHS in Scotland – …
Eisai opens Fycompa UK manufacturing line
September 25, 2012Manufacturing and Production, Sales and Marketing Eisai, Fycompa
Eisai has opened a new solid dose production line for epilepsy drug Fycompa at its UK base in Hatfield, Hertfordshire. …
UK at centre of Eisai plans
September 18, 2012Research and Development, Sales and Marketing CNS, Cancer Drugs Fund, Eisai, Fycompa, Halaven
Diseases of the central nervous system (CNS) and cancer will be the main areas targeted by Japanese firm Eisai as …
Latest content
FibroFind appoints Lee Borthwick as CEO
